Cardinal Health, Inc. $CAH is Iron Triangle Partners LP's 2nd Largest Position

Key Points

• Iron Triangle Partners LP increased its stake in Cardinal Health, Inc. by 61.3%, making it the fund's second largest position, comprising 6.6% of its portfolio with 300,000 shares valued at approximately $41.33 million.
• Insider sales included CEO Jason M. Hollar selling 35,901 shares for about $5.39 million, reflecting a 15.22% decrease in his ownership, while total insider sales reached 271,676 shares valued at roughly $40.49 million over the last quarter.
• Cardinal Health announced a quarterly dividend of $0.5107, translating to an annualized yield of 1.4% and a payout ratio of 31.63%, with the dividend payment scheduled for October 15th.

Iron Triangle Partners LP raised its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 61.3% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 300,000 shares of the company's stock after buying an additional 113,998 shares during the period. Cardinal Health comprises about 6.6% of Iron Triangle Partners LP's portfolio, making the stock its 2nd largest holding. Iron Triangle Partners LP owned 0.13% of Cardinal Health worth $41,331,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of CAH. Integrated Wealth Concepts LLC raised its stake in shares of Cardinal Health by 22.4% during the 4th quarter. Integrated Wealth Concepts LLC now owns 4,083 shares of the company's stock valued at $483,000 after buying an additional 748 shares during the last quarter. Northern Trust Corp grew its position in shares of Cardinal Health by 16.2% during the 4th quarter. Northern Trust Corp now owns 3,037,849 shares of the company's stock valued at $359,286,000 after acquiring an additional 422,755 shares during the period. Lido Advisors LLC lifted its stake in Cardinal Health by 53.3% in the 4th quarter. Lido Advisors LLC now owns 20,252 shares of the company's stock valued at $2,395,000 after buying an additional 7,042 shares in the last quarter. Rehmann Capital Advisory Group lifted its stake in Cardinal Health by 8.2% in the 4th quarter. Rehmann Capital Advisory Group now owns 2,946 shares of the company's stock valued at $348,000 after buying an additional 223 shares in the last quarter. Finally, Freestone Grove Partners LP purchased a new position in Cardinal Health in the 4th quarter valued at about $36,709,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Wall Street Zen lowered Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 2nd. Robert W. Baird increased their price objective on shares of Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a report on Wednesday, August 13th. Citigroup reiterated a "neutral" rating and issued a $170.00 price objective (up previously from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Argus set a $189.00 price objective on shares of Cardinal Health in a report on Friday, August 22nd. Finally, Morgan Stanley reiterated an "overweight" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $165.93.

Insider Transactions at Cardinal Health

In other news, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares of the company's stock, valued at approximately $3,881,969.70. The trade was a 61.45% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jessica L. Mayer sold 38,078 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares in the company, valued at $7,211,370.74. This trade represents a 44.00% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock valued at $40,489,525 over the last quarter. Insiders own 0.09% of the company's stock.

Cardinal Health Price Performance

Shares of CAH stock traded up $0.76 during trading hours on Tuesday, hitting $149.54. The company had a trading volume of 1,161,751 shares, compared to its average volume of 2,421,437. The company's fifty day moving average is $157.10 and its 200 day moving average is $146.46. Cardinal Health, Inc. has a fifty-two week low of $106.54 and a fifty-two week high of $168.44. The stock has a market capitalization of $35.71 billion, a PE ratio of 23.18, a price-to-earnings-growth ratio of 1.26 and a beta of 0.73.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same period in the prior year, the firm earned $1.84 EPS. The firm's revenue for the quarter was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio is presently 31.63%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.